1. Byrne C, Caskey F, Castledine C, et al. UK Renal Registry: 20th Annual Report of the Renal Association. Nephron 2018; 139(Suppl. 1): 24–35.
2.
Koye DN, Shaw JE, Reid CM, et al. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Diabet Med 2017; 34(7): 887–901.
3.
Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabete Obes Metab 2020; 22: 3–15.
4.
Tang SC, Chan GC, Lai KN. Recent advances in managing and understanding diabetic nephropathy. F1000Res 2016; 5: F1000, doi: 10.12688/f1000research.7693.1.
5.
Magee C, Grieve DJ, Watson CJ, et al. Diabetic nephropathy: a tangled web to unweave. Cardiovasc Drugs Ther 2017; 31(5–6): 579–592.
6.
Gnudi L, Gentile G, Ruggenenti P. Oxford Textbook of Clinical Nephrology. Vol. 2. 4th ed. Oxford: Oxford University Press; 2016.
7.
Katayama S, Moriya T, Tanaka S, et al. Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS). Diabetologia 2011; 54: 1025–1031.
8.
Liyanage PL, Lekamwasam S, Weerarathna TP, et al. Prevalence of normoalbuminuric renal insufficiency and associated clinical factors in adult onset diabetes. BMC Nephrology 2018; 19(1): 1–6.
9.
Kim SS, Song SH, Kim IJ, et al. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients. Diabetes Metab Res Rev 2014; 30: 736–741.
10.
KDOQI. KDOQI Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49: S12–S154.
11.
Saha T, Bhattarai A, Batra H, et al. Correlation of microalbuminuria with estimated GFR (eGFR) by Cockcroft–Gault and MDRD formula in type 2 diabetics and hypertensives. Indian J Clin Biochem 2014; 30: 271–274.
12.
Lee HW, Jo AR, Yi DW, et al. Prevalent rate of nonalbuminuric renal insufficiency and its association with cardiovascular disease event in Korean type 2 diabetes. Endocrinol Metab 2016; 31: 577–585.
13.
MacIsaac RJ, Panagiotopoulos S, McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 2006; 29(7): 1560.
14.
Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011; 29: 1802–1809.
15.
Ekinci EI, Jerums G, Skene A, et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 2013; 36(11): 3620–3626.
16.
Boronat M, García-Cantón C, Quevedo V, et al. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus. Ren Fail 2014; 36(2): 166–170, doi: 10.3109/0886022X.2013.835266.
17.
Bonakdaran S, Armanpour P. Evaluation of risk factors of renal involvement in patients with type 2 diabetes. MJMS 2016; 59(5): 211–224.
18.
Siddique A, Murphy TP, Naeem SS, et al. Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes. Catheter Cardiovasc Interv 2019; 93(4): E217–224.
19.
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization; 1999.
20.
KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1–150.
21.
Esteban P, Piero R, Carl E, et al. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. Lancet Diabetes Endocrinol 2015; 3: 382–391.
22.
Yokoyama H, Kawai K, Kobayashi M. Japan diabetes clinical data management study Group. Microalbuminuria is common in Japanese type 2 diabetic patients: a nationwide survey from the Japan diabetes clinical data management study Group (JDDM 10). Diabetes Care 2007; 30: 989–992.
23.
Shikata K, Kodera R, Utsunomiya K, et al. JDCP study group. Prevalence of albuminuria and renal dysfunction, and related clinical factors in Japanese patients with diabetes: the Japan Diabetes Complication and its Prevention prospective study 5. J Diabetes Investig 2020; 11(2): 325–332, doi: 10.1111/jdi.13116.
24.
Aristizábal Gómez LY, Restrepo Valencia CA, Aguirre Arango JV. Clinical characteristic of a population of diabetics type 2 with alteration in the renal function non macroalbuminuric. Colombian J Nephrol 2017; 4(2): 149–158, doi: 10.22265/acnef.4.2.271.
25.
Laranjinha I, Matias P, Mateus S, et al. Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients. Nefrologia 2016; 36(5): 503–509.
26.
Kodgirwar PS, Jajoo SU, Jajoo UN, et al. Nonalbuminuric chronic kidney disease: A dominant presentation in noncommunicable disease population of rural central India. J Family Med Prim Care 2018; 7(2): 442–446.
27.
Mani MK. Experience with a program for prevention of chronic renal failure in India. Kidney Int 2005; 67: S75–S78.
28.
Yokoyama H, Sone H, Oishi M, et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2008; 24(4): 1212–1219.
29.
An J, Cho Y, Yu H, et al. The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. J Korean Med Sci 2009; 24(Suppl. 1): S75.